ProMIS Neurosciences Inc. (PMN)
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.
Address
SUITE 200, 1920 YONGE STREET
TORONTO, A6 M4S 3E2
Founded
2004
Number of Employees
7
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at PMN make a trade.
Creating a free account takes less than one minute